510(k) Report

FDA product code · Immunology

Autoantibodies, Skin (Bullous Pemphigoid 180 And Bullous Pemphigoid 230

OEGClass II21 CFR 866.5660510(k) required3 decisions since 20080 recalls

3 FDA decisions since 2008. No recall names this code.

The device is intended as an aid in the diagnosis of bullous pemphigoid.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of OEG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · OEG

1in 2020

2008: 12009: 12020: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OEG

Too few OEG 510(k)s in any year since 2007 to give a median.

Recalls per year · OEG

No recall names OEG since 2007.

Adverse event reports per year · OEG

No MAUDE report names OEG since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20091—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — OEG by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in OEG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 866.5660.